Sertraline has fungicidal activity against Candida spp. and acts by inhibiting membrane and cell wall biosynthesis
Abstract
Aim: Our study evaluated the activity of sertraline (SER) alone and associated with antifungal drugs in planktonic Candida spp. strains, and investigated its mechanism of action. Materials & methods: Broth microdilution method and minimum fungicidal concentration/MIC ratio were used to assess SER anticandidal activity, and the interaction with antifungals was determined by fractional inhibitory concentration index. The mechanism of action was investigated by flow cytometry and in silico tests. Results: SER inhibited Candida spp. strains at low concentrations by the fungicidal effect and showed no loss of effectiveness when combined. Its action seemed to be related to the membrane and cell wall biosynthesis inhibition. Conclusion: SER has activity against Candida spp. isolated and associated with antifungals, and acts by causing cell wall and membrane damage.
References
- 1. . Emerging fungal infections: new patients, new patterns, and new pathogens. J. Fungi (Basel) 5(3), 67 (2019).
- 2. . Emerging and reemerging fungal infections. Semin. Diagn. Pathol. 36(3), 177–181 (2019).
- 3. . Global and multi-national prevalence of fungal diseases –estimate precision. J. Fungi (Basel) 3(4), 57 (2017).
- 4. . Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science 360(6390), 739–742 (2018).
- 5. . New facets of antifungal therapy. Virulence 8(2), 222–236 (2017).
- 6. . The fungal cell wall as a target for the development of new antifungal therapies. Biotechnol. Adv. 37(6), 107352 (2019).
- 7. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 62(4), e1–e50 (2015).
- 8. . Emerging new targets for the treatment of resistant fungal infections. J. Med. Chem. 61(13), 5484–5511 (2018).
- 9. Copper-only superoxide dismutase enzymes and iron starvation stress in Candida fungal pathogens. J. Biol. Chem. 295(2), 570–583 (2020).
- 10. . The cytochrome bc1 complex as an antipathogenic target. FEBS Lett. 594(18), 2935–2952 (2020).
- 11. . Structural basis for Mep2 ammonium transceptor activation by phosphorylation. Nat. Commun. 7, 11337 (2016).
- 12. . Structural features and thermodynamics of the J4/5 loop from the Candida albicans and Candida dubliniensis group I introns. Biochemistry 43(50), 15822–15837 (2004).
- 13. Multifaceted activities of DNA polymerase η: beyond translesion DNA synthesis. Curr. Genet. 65(3), 649–656 (2019).
- 14. . The Ca-loop in thymidylate kinase is critical for growth and contributes to pyrimidine drug sensitivity of Candida albicans. J. Biol. Chem. 294(27), 10686–10697 (2019).
- 15. Structural insights into telomere protection and homeostasis regulation by yeast CST complex. Nat. Struct. Mol. Biol. 27(8), 752–762 (2020).
- 16. . Drug repositioning: identifying and developing new uses for existing drugs. Nat. Rev. Drug Discov. 3(8), 673–683 (2004).
- 17. Drug repurposing: progress, challenges and recommendations. Nat. Rev. Drug Discov. 18(1), 41–58 (2018).
- 18. . Searching for new strategies against biofilm infections: colistin–AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms. PLOS ONE 12(3), e0174654 (2017).
- 19. Non-antibiotic drug repositioning as an alternative antimicrobial approach. Antibiotics 11(6), 816 (2022).
- 20. In vitro anti-Candida activity of selective serotonin reuptake inhibitors against fluconazole-resistant strains and their activity against biofilm-forming isolates. Microb. Pathog. 107, 341–348 (2017).
- 21. . Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertraline. Clin. Infect. Dis. 33(12), e135–e136 (2001).
- 22. . Serotonin reuptake inhibitors effect on fluconazole activity against resistant Candida glabrata strains. J. Glob. Antimicrob. Resist 29, 49–54 (2022).
- 23. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard – Third Edition M27-A3 (2008).
- 24. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Fourth Informational Supplement M27-S4 (2012).
- 25. . Synthesis, characterization and antimicrobial evaluation of novel halopyrazole derivatives. Journal of Saudi Chemical Society 17(2), 237–243 (2013).
- 26. Antifungal activity of naphthoquinoidal compounds in vitro against fluconazole-resistant strains of different Candida species: a special emphasis on mechanisms of action on Candida tropicalis. PLOS ONE 9(5), e93698 (2014).
- 27. Synergistic effects of amiodarone and fluconazole on Candida tropicalis resistant to fluconazole. Antimicrob. Agents Chemother. 57(4), 1691–700 (2013).
- 28. . Application of the single cell gel electrophoresis on yeast cells. Mutat. Res. 513, 69–74 (2002).
- 29. Evaluation of genotoxicity and mutagenicity of ketamine on human peripheral blood leukocytes and in Salmonella typhimurium. Toxicol. In Vitro 62, 104718 (2020).
- 30. Antimicrobial and cytotoxic activities of synthetically derived tambjamines C and E-J, BE-18591, and a related alkaloid from the marine bacterium Pseudoalteromonas tunicata. Chem. Biodivers. 7(5), 1311–1324 (2010).
- 31. . MarvinSketch and MarvinView: molecule applets for the world wide web (1999). https://chemaxon.com/blog/presentation/marvinsketch-and-marvinview-molecule-applets-for-the-world-wide-web
- 32. . Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J. Cheminform. 4(1), 17 (2012).
- 33. . Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94. J. Comput. Chem. 17(5–6), 490–519 (1996).
- 34. Anti-MRSA activity of curcumin in planktonic cells and biofilms and determination of possible action mechanisms. Microb. Pathog. 155, 104892 (2021).
- 35. . Structure of the catalytic core of S. cerevisiae DNA polymerase η. Mol Cell 8(2), 417–426 (2001).
- 36. . Analyses of Candida Cdc13 orthologues revealed a novel OB fold dimer arrangement, dimerization-assisted DNA binding, and substantial structural differences between Cdc13 and RPA70. Mol. Cell. Biol. 32(1), 186–198 (2012).
- 37. Candida albicans SOD5 represents the prototype of an unprecedented class of Cu-only superoxide dismutases required for pathogen defense. Proc. Natl Acad. Sci. USA 111(16), 5866–5871 (2014).
- 38. . Minor structural consequences of alternative CUG codon usage (Ser for Leu) in Candida albicans exoglucanase. Protein Eng. 13(10), 735–738 (2000).
- 39. Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J. Biol. Chem. 292(16), 6728–6743 (2017).
- 40. Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (part-2). Bioorg. Med. Chem. Lett. 25(9), 1831–1835 (2015).
- 41. . Specific roles of protein-phospholipid interactions in the yeast cytochrome bc1 complex structure. EMBO J. 20(23), (2001).
- 42. . Using AutoDock 4 and Vina with AutoDockTools: A Tutorial. CA, USA (2011).
- 43. . Software news and update AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455–461 (2010).
- 44. UCSF Chimera – a visualization system for exploratory research and analysis. J. Comput. Chem. 25(13), 1605–1612 (2004).
- 45. . AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455–461 (2009).
- 46. Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease. Microb. Pathog. 148, 104365 (2020).
- 47. . An alternative method for the evaluation of docking performance: RSR vs RMSD. J. Chem. Inf. Model. 48(7), 1411–1422 (2008).
- 48. Antifungal activity of etomidate against growing biofilms of fluconazole-resistant Candida spp. strains, binding to mannoproteins and molecular docking with the ALS3 protein. J. Med. Microbiol. 69(10), 1221–1227 (2020).
- 49. Evaluation of the synergistic antifungal activity of micafungin and voriconazole plus sertraline against Candida auris. Braz. J. Microbiol. 53(4), 2003–2008 (2022).
- 50. . Amphotericin B: side effects and toxicity. Rev. Iberoam. Micol. 26(4), 223–227 (2009).
- 51. . Fungicidal versus fungistatic therapy of invasive Candida infection in non-neutropenic adults: a meta-analysis. Mycology 9(2), 116–128 (2018).
- 52. . Sertraline demonstrates fungicidal activity in vitro for Coccidioides immitis. Mycology 7(3), 99–101 (2016).
- 53. . In vitro antifungal activity of sertraline and synergistic effects in combination with antifungal drugs against planktonic forms and biofilms of clinical Trichosporon asahii isolates. PLOS ONE 11(12), e0167903 (2016).
- 54. . Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro. J. Appl. Microbiol. 128(2), 426–437 (2020).
- 55. . The mechanism of antifungal action of essential oil from dill (Anethum graveolens l.) on Aspergillus flavus. PLOS ONE 7(1), e30147 (2012).
- 56. . Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 48(2), 158–167 (2012).
- 57. . Oxidative stress by antimicrobial peptide pleurocidin triggers apoptosis in Candida albicans. Biochimie 93(10), 1873–1879 (2011).
- 58. Etomidate is devoid of genotoxicty and mutagenicity in human lymphocytes and in the Salmonella typhimurium/microsomal activation test. Toxicol. In Vitro 68, 104946 (2020).